Annual Option Grant. The Executive shall be entitled to be awarded an annual stock option under the Plan targeted at 0.37% of the Company’s outstanding shares Common Stock on the date of grant. Such options shall be exercisable for a 10-year period commencing on the date of grant, have an exercise price equal to the closing price of the Common Stock on the date of grant, and shall vest in 48 equal monthly installments over the four-year period following the date of grant. Notwithstanding the foregoing, any options issued under this Section 3(c)(ii) shall be subject to the approval of the Board or the Compensation Committee.
Annual Option Grant. For each compensation year during the Term and commencing with the 2018/2019 compensation year, Executive will be entitled to receive an annual option grant (the “Annual Grant”), payable with respect to each compensation year of the Term, within ninety (90) days of the completion of such compensation year, provided Executive is employed by the Company on such date. The final determination on the amount, if any, of the Annual Grant will be made by, and in the sole discretion of the Compensation Committee (or the Board, if such committee has been dissolved), based on goals and objectives approved by the Compensation Committee of the Board (or the Board, if such committee has been dissolved). The target Annual Grant for the 2018/2019 compensation year will be $750,000. The Annual Grant shall have a term of ten years and shall vest in four (4) equal installments on each of the succeeding four anniversary dates of the date of grant, provided Executive remains continuously employed by Company through each such vesting date. The Annual Grant shall be made pursuant to the Soliton, Inc. 2018 Stock Plan, and shall in all respects be subject to the terms and conditions of such plan.
Annual Option Grant. Employee shall be eligible for annual grants of non-qualified stock options (“Annual Option Grant”) to purchase Company common stock, no par value (“Common Stock”) pursuant to the Company’s Stock Option Plan adopted May 29, 2002 or any successor option plan adopted by the Company and approved by shareholders (the “Option Plan”). The Annual Option Grant shall have a target value, based on an accepted option pricing methodology chosen by the Company, of 100% of Employee’s base salary for the year in which such Annual Option Grant is made, subject to the following:
Annual Option Grant. For each compensation year during the Term commencing with the compensation year commencing June 1, 2023, Executive will be entitled to receive an annual option grant under the Moleculin Biotech, Inc. 2015 Stock Plan, or any future stock plans approved by the Company’s stockholders (the “Stock Plan”) (the “Annual Grant”), subject to the availability of shares of common stock under the Stock Plan, within ninety (90) days of the completion of such compensation year, provided Executive is employed by the Company on such date. The final determination on the amount, if any, of the Annual Grant will be made by, and in the sole discretion of, the Compensation Committee (or the Board, if such committee has not been formed or has been dissolved), based on goals and objectives approved by the Compensation Committee of the Board (or the Board, if such committee has not been formed or has been dissolved). Unless otherwise determined by the Compensation Committee (or the Board, if such committee has not been formed or has been dissolved), the Annual Grant shall have a term of ten years and shall vest in four (4) equal installments on each of the succeeding four anniversary dates of the date of grant, provided Executive remains continuously employed by Company through each such vesting date. The Annual Grant shall be made pursuant to the Stock Plan, and shall in all respects be subject to the terms and conditions of such plan.
Annual Option Grant. Executive shall be entitled to receive a grant of an option to purchase 100,000 shares of common stock of the Company on February 25, 2014 and on each February 25 thereafter , provided Executive remains employed by the Company on each such date. Each such grant shall be made pursuant to the Company’s 2005 Incentive Stock Option Plan, as such plan may be amended, or a subsequent stock option plan as may be adopted by the Company (the “Plan”). The option exercise price will be equal to the Fair Market Value of the Company’s common stock on the date of grant and shall be fully vested as of the grant date. The terms of each such grant of stock options shall be set forth in a separate Stock Option Agreement between the Company and the Executive and shall be pursuant to the Plan.
Annual Option Grant. As soon as practicable after the end of each ------------------- fiscal year ending during the Employment Period, as long as the Executive is employed by the Company on that date, the Executive shall receive a grant of stock options from Equivest covering shares of the common stock of Equivest (the "Common Stock") based upon achievement of the Pre-Tax Profit Targets for such fiscal year as follows: (i) if the Company reaches at least 100%, but less than 125%, of the Pre-Tax Profit Target for a fiscal year, the Executive shall receive for such fiscal year an option covering 30,000 shares of the Common Stock; and (ii) in lieu of the grant of options described in clause (i) of this sentence, if the Company equals or exceeds 125% of the Pre-Tax Profit Target for a fiscal year, the Executive shall receive for such fiscal year an option covering 60,000 shares of the Common Stock. Options covering shares of Common Stock shall vest and become exercisable at a rate of 20% per year for a five- year period and options covering shares of Common Stock shall expire ten years from their dates of grant. The exercise purchase price of an option shall be the fair market value of a share of the Common Stock on the date of grant of the option. All such options shall be subject to a stock option agreement entered into between the parties hereto on terms consistent with the foregoing; provided, however, that the options shall be effective as of the date of grant -------- ------- in accordance with the terms and conditions contained herein, irrespective of whether a stock option agreement has been executed by the parties. Except as expressly provided in Section 7(a)(iv) of this Agreement, all unvested options shall immediately expire upon the date of the Executive's termination of employment. No options shall be granted to the Executive after the date of his termination of employment.
Annual Option Grant. For each year during the Term, Executive will be entitled to receive an annual option grant under the Volcon, Inc. 2021 Stock Plan, or any future stock plans approved by the Company’s stockholders (the “Stock Plan”) (the “Annual Grant”), subject to the availability of shares of common stock under the Stock Plan, within ninety (90) days of the completion of such compensation year, provided Executive is employed by the Company on such date. The final determination on the amount, if any, of the Annual Grant will be made by, and in the sole discretion of, the Compensation Committee (or the Board, if such committee has not been formed or has been dissolved), based on goals and objectives approved by the Compensation Committee of the Board (or the Board, if such committee has not been formed or has been dissolved). The Annual Grant shall be made pursuant to the Stock Plan, and shall in all respects be subject to the terms and conditions of such plan. For 2024, the Annual Grant shall (i) be issued after the date of the Company’s 2024 annual meeting and on or prior to the date the Company issues equity compensation to any other executive officers or members of the Board; (ii) be for a number of shares equal to 10% of the fully diluted number of shares of Company common stock outstanding on the date of grant and shall vest on the earlier of one year after issuance or on the date when at least 90% of the Company’s convertible promissory notes outstanding on the date hereof are no longer outstanding; (iii) have an exercise price equal to the closing price of the Common Stock on the date of issuance; and (iv) shall be subject to the approval by the Company’s shareholders to increase the number of shares of common stock available for issuance under the Stock Plan.
Annual Option Grant. Consultant will receive an annual grant of [ ] options to purchase Alnylam stock and [ ] options to purchase Isis stock, subject in both cases to the terms of the respective stock plans and policies of Alnylam and Isis, as applicable, as compensation for Consultant’s continued advisory role. Schedule 4.5-11 SCHEDULE 4.6 INITIAL MANAGING BOARD MEMBERS Name Title TBD President, Regulus Therapeutics LLC Dxxxx Xxxxxxxxx, Ph.D. Independent Director nominated by Alnylam TBD Independent Director nominated by Isis
Annual Option Grant. For each compensation year during the Term and commencing with the 2022 compensation year, Employee will be entitled to receive an annual option grant (the "Annual Grant"), payable with respect to each compensation year of the Term. The final determination on the amount, if any, of the Annual Grant will be made by, and in the sole discretion of the Compensation Committee (or the Board, if such committee has been dissolved), based on goals and objectives approved by the Compensation Committee of the Board (or the Board, if such committee has been dissolved). The Annual Grant shall vest in four (4) equal installments on each of the succeeding four anniversary dates of the date of grant, provided Employee remains continuously employed by Company through each such vesting date.
Annual Option Grant. Commencing in November 2006, Employee will be eligible to receive an annual target option grant equal to the greater of 25,000 shares of Class A common stock or the amount set for other Senior Vice Presidents of the Company (“SVPs”) (the “Annual Option”), with an exercise price equal to 100% of the fair market value of the underlying shares on the date of grant, subject to a four-year vesting schedule, vesting with respect to 25% of the underlying shares one year after the grant and vesting with respect to the remaining shares in 12 equal installments on a quarterly basis thereafter. Each Annual Option will be subject to the terms and conditions of the Company’s equity incentive plans. The size of the option grants shall be established by the Compensation Committee and may be larger or smaller than the target size, depending on the Employee’s satisfaction of performance criteria (which may include Company overall performance criteria) established by the President and Chief Executive Officer or Compensation Committee of the Board. The Annual Option granted in November 2006 shall be prorated from the Commencement Date.
